Progression of Parkinson's disease follows brain connectivity

January 12, 2018, McGill University
Progression of Parkinson's disease follows brain connectivity
Credit: McGill University

A study by a group of researchers including those from The Montreal Neurological Institute and Hospital of McGill University has tested the theory that brain degeneration in Parkinson's disease (PD) originates in subcortical regions and spreads along neural networks to the cerebral cortex.

By analyzing data on PD patients and healthy controls collected over one year, the researchers found that closely connected to subcortical regions showed the most degeneration over the one-year period in PD patients, and that this happens earlier than previously thought.

Their study, published in the journal Nature Communications on Jan. 2, 2018, supports the theory that PD progression is correlated to brain connectivity, thought to be a consequence of propagation of a toxic protein. This work sheds light on the mechanism of Parkinson's Disease and may guide the development and testing of therapeutic interventions.

Explore further: New study maps the progression of Parkinson's disease within the brain

More information: Y. Yau et al. Network connectivity determines cortical thinning in early Parkinson's disease progression, Nature Communications (2017). DOI: 10.1038/s41467-017-02416-0

Related Stories

New study maps the progression of Parkinson's disease within the brain

September 22, 2015
Scientists at the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and the McGill University Health Centre, have made advances in understanding the process involved in the progression and spread ...

Study describes changes to structural brain networks after radiotherapy for brain tumors

June 26, 2017
Researchers compared the thickness of brain cortex in patients with brain tumors before and after radiation therapy was applied and found significant dose-dependent changes in the structural properties of cortical neural ...

Cognitive status doesn't impact cortical A-beta, tau in Parkinson's

December 12, 2017
(HealthDay)—Patterns of cortical β-amyloid (Aβ) and tau are not different for patients with Parkinson's disease (PD) who are cognitively normal (PD-CN) or with mild cognitive impairment (MCI) and for healthy adults, according ...

New study on cerebral astrocytes in depression and suicide

June 2, 2015
A new study published by the team of Naguib Mechawar, Ph.D., a researcher with the McGill Group for Suicide Studies (MGSS) of the Douglas Institute (CIUSSS de l"Ouest-de-l"Ile de Montreal) and associate professor in the Department ...

Brain disconnections may contribute to Parkinson's hallucinations

September 27, 2017
Researchers have found that disconnections of brain areas involved in attention and visual processing may contribute to visual hallucinations in individuals with Parkinson's disease, according to a new study published online ...

Study challenges model of Alzheimer's disease progression

November 4, 2016
Alzheimer's disease is a neurodegenerative disorder for which, despite years of research, there are no effective treatments or cures.

Recommended for you

New evidence sheds light on how Parkinson's disease may happen

June 14, 2018
Researchers at Baylor College of Medicine and Texas Children's Hospital have identified unexpected new key players in the development of an early onset form of Parkinson's disease called Parkinsonism. These key players are ...

Scientists unravel molecular mechanisms of Parkinson's disease

June 12, 2018
Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson's disease.

First photoactive drug to fight Parkinson's disease

June 8, 2018
An international team has designed the first potentially therapeutic photoactive drug, MRS7145, to fight Parkinson's disease, according to the new article in Journal of Controlled Release.

Researchers address sleep problems in Parkinson's disease

June 7, 2018
A team of researchers at VIB and KU Leuven has uncovered why people with a hereditary form of Parkinson's disease suffer from sleep disturbances. The molecular mechanisms uncovered in fruit flies and human stem cells also ...

Drugs that suppress immune system may protect against Parkinson's

May 31, 2018
People who take drugs that suppress the immune system are less likely to develop Parkinson's disease, according to a study from Washington University School of Medicine in St. Louis.

Early synaptic dysfunction found in Parkinson's Disease

May 24, 2018
Northwestern Medicine scientists identified a cellular mechanism that leads to neurodegeneration in patients with Parkinson's disease, according to a study published in Proceedings of the National Academy of Sciences.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.